GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHY) » Definitions » Shares Buyback Ratio %

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Shares Buyback Ratio % : -0.01 (As of Apr. 27, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Aspen Pharmacare Holdings Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Aspen Pharmacare Holdings's current shares buyback ratio was -0.01%.


Aspen Pharmacare Holdings Shares Buyback Ratio % Historical Data

The historical data trend for Aspen Pharmacare Holdings's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings Shares Buyback Ratio % Chart

Aspen Pharmacare Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.06 0.08 2.25 0.16

Aspen Pharmacare Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.25 0.16 - -0.01

Aspen Pharmacare Holdings Shares Buyback Ratio % Calculation

Aspen Pharmacare Holdings's Shares Buyback Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2022 ) - Shares Outstanding (EOP) (A: Jun. 2023 )) / Shares Outstanding (EOP) (A: Jun. 2022 )
=(444.946 - 444.238) / 444.946
=0.16%

Aspen Pharmacare Holdings's Shares Buyback Ratio for the quarter that ended in Dec. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2023 ) - Shares Outstanding (EOP) (A: Dec. 2023 )) / Shares Outstanding (EOP) (A: Jun. 2023 )
=(444.238 - 444.300) / 444.238
=-0.01%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aspen Pharmacare Holdings Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description

Traded in Other Exchanges
Address
Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Headlines

From GuruFocus

Value Idea Contest: Aspen Pharmacare

By Matthew Sipos Matthew Sipos 03-17-2019